Key facts
- This page summarizes Robert J. Trenschel's Form 4 filing for PALISADE BIO, INC. (PALI).
- 8 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2024, 15:08.
Robert J. Trenschel - 08 Feb 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)
- Reporting relationship
- Director
- Issuer ticker
- PALI
- Reported as of
- 08 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Feb 2024, 15:08:40 UTC
- Prior SEC filing
- 24 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Trenschel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert J. Trenschel filed Form 4 for PALISADE BIO, INC. (PALI) on 13 Feb 2024.
Change
- Previous filing in this sequence was filed on 24 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PALI
transaction
Common Stock, par value $0.01
Options Exercise
- Transaction value
- $0
- Shares
- +5,100
- Change %
- Price
- $0.000000
- Shares after
- 5,100
- Date
- 08 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
PALI
transaction
Common Stock, par value $0.01
Options Exercise
- Transaction value
- $0
- Shares
- +5,820
- Change %
- +114%
- Price
- $0.000000
- Shares after
- 10,920
- Date
- 08 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PALI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -5,100
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,100
- Exercise price
- Footnotes
- F3, F5
PALI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -5,820
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,820
- Exercise price
- Footnotes
- F4, F5
PALI
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -12,160
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,160
- Exercise price
- $1.60
- Footnotes
- F6, F7
PALI
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- +12,160
- Change %
- Price
- $0.000000
- Shares after
- 12,160
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,160
- Exercise price
- $1.60
- Footnotes
- F6, F7
PALI
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -6,880
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,880
- Exercise price
- $0.5900
- Footnotes
- F6, F8
PALI
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- +6,880
- Change %
- Price
- $0.000000
- Shares after
- 6,880
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,880
- Exercise price
- $0.5900
- Footnotes
- F6, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Robert J. Trenschel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 8 footnotes
Footnote F1
Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Footnote F2
Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Footnote F3
This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding.
Footnote F4
This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding.
Footnote F5
Each restricted stock unit represents the right to receive one share of common stock.
Footnote F6
Each option represents the right to purchase one share of common stock at the exercise price.
Footnote F7
Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Footnote F8
Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.